70114-210 : Yusimry 40 mg/.8ml Subcutaneous Injection, Solution
NDC: | 70114-210 |
Labeler: | Coherus Biosciences Inc |
Product Type: | Human Prescription Drug |
Drug Name: | Yusimry |
Dosage Form: | Subcutaneous Injection, Solution |
Application #: | BLA761216 |
Rev. Date: |
NDC Package Codes:
- 70114-210-02: 2 SYRINGE, GLASS IN 1 CARTON (70114‑210‑02) / .8 ML IN 1 SYRINGE, GLASS
Active Ingredients:
- Adalimumab
Dosage Strength:
- 40 mg/.8mL
Pharmaceutical Classes:
- Antibodies
- Monoclonal [CS]
- Tumor Necrosis Factor Blocker [EPC]
- Tumor Necrosis Factor Receptor Blocking Activity [MoA]
Related Products:
Based on records with the same trade name.- 70114-220 Yusimry 40 mg/.8ml Subcutaneous Injection, Solution by Coherus Biosciences Inc
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 70114-130Next: 70114-220 >
Related Discussions:
Humira (adalimumab) for pain
I’m on Humira (adalimumab) for RA joint pain and would like to know how other people are doing on it? I’m do... 2 replies
I’m on Humira (adalimumab) for RA joint pain and would like to know how other people are doing on it? I’m do... 2 replies
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.